SCHOTT PHARMA : Jefferies reaffirms its Neutral rating -November 07, 2023 at 01:10 am EST

In a research note, Jefferies analyst James Vane-Tempest has maintained his recommendation on the stock with a Neutral rating.

Related Keywords

,James Vane Tempest ,Markets ,